Press release |

BEITEN BURKHARDT Advises B. Braun on Takeover of Nephtec

Dusseldorf, 9 July 2019 – The international law firm BEITEN BURKHARDT has advised B. Braun Avitum AG, a subsidiary of B. Braun Group headquartered in Melsungen, Germany, and one of the world's leading system providers for extracorporeal blood treatment (dialysis), a component of the private Centec Group headquartered in Maintal, Germany, on the acquisition of the business operations of Nephtec GmbH. With this takeover B. Braun strengthens its product portfolio in the field of central processing of dialysis concentrates. The parties have agreed to keep the transaction volume confidential.

Through its cooperation with Intermedt Medizin & Technik GmbH, B. Braun already has extensive experience in the field of fully automatic concentrate preparation in dialysis. This is a simple, economical and environmentally friendly method of producing dialysis concentrates reliably and safely on site in the centre itself.

With this acquisition, B. Braun is responding to increasing global demand in this area and is also expanding its existing network of production sites.

BEITEN BURKHARDT has comprehensively advised B. Braun Avitum AG on all legal aspects in relation to this Asset Deal.

Dr. Sebastian Weller
Tel.: +49 211 518989–134


BEITEN BURKHARDT Advises B. Braun on Takeover of Nephtec.pdf